Vivos (RDGL) Cash & Current Investments (2010 - 2025)
Vivos' (RDGL) quarterly Cash & Current Investments came in at $1.6 million in Q4 2025, down 29.56% year-on-year from $2.2 million in Q4 2024, and down 29.23% quarter-over-quarter from $2.2 million in Q3 2025.
Vivos (RDGL) Cash & Current Investments (2010 - 2025) Analysis & Trends
Vivos has disclosed Cash & Current Investments across 16 years of filings, most recently posting $1.6 million for Q4 2025.
- Cash & Current Investments for Q4 2025 came in at $1.6 million, down 29.56% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.6 million (down 29.56% YoY), and the FY2025 annual result was $1.6 million, down 29.56% from the prior year.
- Cash & Current Investments came in at $1.6 million for Q4 2025 at Vivos, down from $2.2 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $3.3 million in Q1 2025 to a low of $1.1 million in Q2 2022.
- The 5-year median for Cash & Current Investments is $1.7 million (2022), against an average of $1.8 million.
- Across the five-year window, Cash & Current Investments surged 13202.47% in 2021 and slumped 51.46% in 2022, its largest moves.
- Vivos' Cash & Current Investments stood at $1.6 million in 2021, then grew by 6.22% to $1.7 million in 2022, then decreased by 6.67% to $1.6 million in 2023, then surged by 38.95% to $2.2 million in 2024, then decreased by 29.56% to $1.6 million in 2025.
- The last three Cash & Current Investments figures came in at $1.6 million (Q4 2025), $2.2 million (Q3 2025), and $2.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 8.38 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.12 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Vivos | - | - | -3,105.00 | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.56 Mn |
| Sep 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | 2.66 Mn |
| Mar 31, 2025 | 3.27 Mn |
| Dec 31, 2024 | 2.21 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | 1.37 Mn |
| Dec 31, 2023 | 1.59 Mn |
| Sep 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | 1.75 Mn |
| Mar 31, 2023 | 1.41 Mn |
| Dec 31, 2022 | 1.71 Mn |
| Sep 30, 2022 | 1.99 Mn |
| Jun 30, 2022 | 1.05 Mn |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 1.61 Mn |
| Sep 30, 2021 | 1.99 Mn |
| Jun 30, 2021 | 2.16 Mn |
| Mar 31, 2021 | 2.51 Mn |